Janney Montgomery Scott’s Avadel Pharmaceuticals AVDL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-15,531
Closed -$106K 2314
2022
Q1
$106K Sell
15,531
-29,227
-65% -$199K ﹤0.01% 2170
2021
Q4
$362K Buy
44,758
+3,472
+8% +$28.1K ﹤0.01% 1897
2021
Q3
$405K Sell
41,286
-50
-0.1% -$490 ﹤0.01% 1789
2021
Q2
$278K Sell
41,336
-4,950
-11% -$33.3K ﹤0.01% 1957
2021
Q1
$418K Buy
46,286
+22,631
+96% +$204K ﹤0.01% 1662
2020
Q4
$158K Buy
+23,655
New +$158K ﹤0.01% 2129
2019
Q1
Sell
-141,856
Closed -$366K 1999
2018
Q4
$366K Sell
141,856
-85,717
-38% -$221K ﹤0.01% 1457
2018
Q3
$999K Buy
227,573
+29,350
+15% +$129K 0.01% 1037
2018
Q2
$1.22M Buy
198,223
+3,000
+2% +$18.4K 0.01% 893
2018
Q1
$1.42M Buy
195,223
+5,250
+3% +$38.3K 0.01% 809
2017
Q4
$1.56M Sell
189,973
-10,003
-5% -$82K 0.02% 759
2017
Q3
$2.1M Buy
+199,976
New +$2.1M 0.02% 595
2017
Q1
Sell
-123,426
Closed -$1.28M 1742
2016
Q4
$1.28M Sell
123,426
-11,674
-9% -$121K 0.02% 675
2016
Q3
$1.68M Sell
135,100
-104,700
-44% -$1.3M 0.03% 486
2016
Q2
$2.58M Buy
239,800
+123,900
+107% +$1.33M 0.05% 257
2016
Q1
$1.28M Buy
115,900
+14,200
+14% +$157K 0.03% 456
2015
Q4
$1.24M Buy
101,700
+29,500
+41% +$360K 0.03% 486
2015
Q3
$1.18M Buy
72,200
+6,900
+11% +$113K 0.03% 478
2015
Q2
$1.38M Sell
65,300
-6,400
-9% -$136K 0.03% 631
2015
Q1
$1.29M Buy
71,700
+8,745
+14% +$157K 0.02% 744
2014
Q4
$1.08M Buy
62,955
+21,455
+52% +$368K 0.02% 836
2014
Q3
$594K Buy
41,500
+16,500
+66% +$236K 0.01% 1157
2014
Q2
$375K Buy
25,000
+9,000
+56% +$135K 0.01% 1439
2014
Q1
$214K Buy
16,000
+3,000
+23% +$40.2K 0.01% 1715
2013
Q4
$105K Buy
13,000
+2,000
+18% +$16.1K ﹤0.01% 1906
2013
Q3
$72.2K Buy
+11,000
New +$72.2K ﹤0.01% 1836